Effect of Galcanezumab on PHQ-9 and GAD-7 in Patients with Migraine: A Real-world Study in Japan
Kota Oshima(Keio University), Tsubasa Takizawa(Keio University), Jin Nakahara(Keio University Hospital), Koji Sekiguchi(Keio University), Kei Ishizuchi(Keio University Hospital), Keiko Ihara(Keio University), Nobuyuki Takahashi(Keio University), Narumi Watanabe(Keio University Hospital), Ryo Takemura(Keio University Hospital)
Cited by 2
Related Papers
Hallmarks of primary headache: part 1 – migraine
|The Journal of Headache and Pain|2024|174
Spreading depolarizations trigger caveolin‐1–dependent endothelial transcytosis
|Annals of Neurology|2018|107
International Headache Society Global Practice Recommendations for Preventive Pharmacological Treatment of Migraine
|Cephalalgia|2024|107
International Headache Society global practice recommendations for the acute pharmacological treatment of migraine
|Cephalalgia|2024|106
Spreading depression as a preclinical model of migraine
|The Journal of Headache and Pain|2019|104